Unique ID issued by UMIN | UMIN000041462 |
---|---|
Receipt number | R000047313 |
Scientific Title | The differences in effectiveness of hydrogel wound covering/protective material (Episil) for oral mucositis caused by chemotherapy and chemoradiotherapy due to the commencement time. - A prospective observational study - |
Date of disclosure of the study information | 2020/08/19 |
Last modified on | 2022/02/21 12:01:40 |
The impact of the commencement time of hydrogel wound covering/protective material (Episil) for oral mucositis caused by chemotherapy and radiotherapy on cancer patients and cancer treatments. - A prospective observational study -
An observational study on Episil for chemotherapy and radiotherapy.
The differences in effectiveness of hydrogel wound covering/protective material (Episil) for oral mucositis caused by chemotherapy and chemoradiotherapy due to the commencement time. - A prospective observational study -
An observational study on the appropriate time of Episil commencement for oral mucositis caused by chemotherapy and chemoradiotherapy.
Japan |
Head and neck cancer, Hematological malignancy
Hematology and clinical oncology | Oto-rhino-laryngology | Dental medicine |
Malignancy
NO
To evaluate the differences in effectiveness of hydrogel wound covering/protective material for oral mucositis due to the commencement time.
Efficacy
Exploratory
Not applicable
Oral pain
Oral mucositis
Body weight
Administration of opioid
Blood test results
Observational
20 | years-old | <= |
Not applicable |
Male and Female
1)Allogeneic hematopoietic stem cell transplant patients and head and neck chemo-radiotherapy patients.
2)Patients who are considered to be appropriate using hydrogel wound covering/protection material.
1)Oral cancer patients.
2)Patients with wounds except for oral mucositis caused by chemotherapy or radiotherapy.
3)Patients with pain management using opioids before the commencement of hydrogel wound covering/protection material application.
4)Patients who are determined to be inappropriateb y the attending physician.
45
1st name | Kouji |
Middle name | |
Last name | Katsura |
Niigata University Medical and Dental Hospital
Department of Oral Radiology
951-8520
1-754 Asahimachi-dori, Chuo-ku, Niigata city, Niigata, Japan
025-223-6161
katsu@dent.niigata-u.ac.jp
1st name | Kouji |
Middle name | |
Last name | Katsura |
Niigata University Medical and Dental Hospital
Department of Oral Radiology
951-8520
1-754 Asahimachi-dori, Chuo-ku, Niigata city, Niigata, Japan
025-223-6161
katsu@dent.niigata-u.ac.jp
NIigata University
None
Other
Niigata University Medical and Dental Hospital
1-754 Asahimachi-dori, Chuo-ku, Niigata city, Niigata, Japan
025-227-2625
ethics@adm.niigata-u.ac.jp
NO
2020 | Year | 08 | Month | 19 | Day |
None
Unpublished
None
45
When our results compare with that of historical control, the degree of pain was better than both the expected value and the threshold value of our setting. The incidence of grade 3 oral mucositis was 14%, which was lower than the incidence of chemoradiotherapy and IMRT.
2022 | Year | 02 | Month | 19 | Day |
Head and neck chemoradiotherapy patients
considaration of main docter
NOne
Pain, mucositis
Completed
2019 | Year | 09 | Month | 01 | Day |
2019 | Year | 10 | Month | 01 | Day |
2019 | Year | 12 | Month | 01 | Day |
2020 | Year | 12 | Month | 31 | Day |
Approval ID: 2019-0001
2020 | Year | 08 | Month | 19 | Day |
2022 | Year | 02 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047313